rss
Br J Ophthalmol 2006;90:1004-1009 doi:10.1136/bjo.2006.090589
  • Clinical science
    • Extended reports

Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study

  1. L D Sjö1,
  2. E Ralfkiaer2,
  3. B R Juhl2,
  4. J U Prause1,3,
  5. T Kivelä4,
  6. C Auw-Haedrich5,
  7. F Bacin6,
  8. M Carrera7,
  9. S E Coupland8,
  10. B Delbosc9,
  11. N Ducrey10,
  12. B Kantelip11,
  13. J L Kemeny12,
  14. P Meyer13,
  15. N C Sjö1,
  16. S Heegaard1
  1. 1Eye Pathology Institute, University of Copenhagen, Denmark
  2. 2Department of Pathology, Rigshospitalet, Copenhagen, Denmark
  3. 3Department of Ophthalmology, Rigshospitalet, Copenhagen, Denmark
  4. 4Department of Ophthalmology, Helsinki University Central Hospital, Finland
  5. 5Department of Ophthalmology, University Hospital in Freiburg, Germany
  6. 6Department of Ophthalmology, University Hospital of G Montpied, Clermont-Ferrand, France
  7. 7Department of Ophthalmic Pathology, Hospital of Bellvitge, University of Barcelona, Spain
  8. 8Department of Cellular and Molecular Pathology, University of Liverpool, Liverpool, UK
  9. 9Department of Ophthalmology, University Hospital of Besançon, France
  10. 10Department of Ophthalmology, Jules Gonin Hospital, Lausanne, France
  11. 11Department of Pathology, University Hospital of Besançon, France
  12. 12Department of Pathology, University Hospital of G Montpied, Clermont-Ferrand, France
  13. 13Department of Ophthalmic Pathology, University of Basle, Switzerland
  1. Correspondence to: Steffen Heegaard MD, Eye Pathology Institute, University of Copenhagen, Denmark, Frederik V’s vej 11,1 DK-2100 Copenhagen, Denmark; sh{at}eyepath.ku.dk
  • Accepted 8 April 2006
  • Published Online First 3 May 2006

Abstract

Aim: To define the clinical and histopathological characteristics of primary lacrimal sac lymphoma in a predominantly white population.

Methods: Specimens of lacrimal sac lymphoma and follow up data were solicited from members of the Ophthalmic Oncology Task Force of the European Organization for Research and Treatment of Cancer (EORTC) and the European Ophthalmic Pathology Society (EOPS). Specimens were stained with haematoxylin and eosin and an immunohistochemical panel against leucocyte antigens was applied. Diagnosis was reached by consensus of five experienced pathologists according to the World Health Organization classification system. The histopathological findings were correlated with the clinical data.

Results: Of 15 primary lacrimal sac lymphomas, five (33%) were diffuse large B cell lymphoma (DLBCL), five (33%) were extranodal marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT lymphoma), three were classified as “transitional MALT lymphoma,” being in transition from MALT lymphoma to DLBCL, and two were unclassified B cell lymphomas. Nine of the patients were female, and the median age at the time of diagnosis was 71 years (range 45–95 years). The most frequent presenting symptoms were epiphora (85%), swelling in the region of the lacrimal sac (79%), and dacryocystitis (21%). All but one patient presented in stage I. Systemic spread occurred in three of nine patients (33%). The 5 year overall survival was 65%.

Conclusions: DLBCL and MALT lymphoma are equally common in the lacrimal sac in contrast with the remaining periorbital and/or orbital region where MALT lymphoma predominates.

Footnotes

  • Competing interests: none.

  • Presented at European Association for Vision and Eye Research, Vilamoura, Portugal, September 2004.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.